ÂÜÀòÂÒÂ×

Steve Martin is a seasoned finance professional with nearly 40 years of experience, culminating in a retirement from a full-time career in July 2022. Having served as Chief Financial Officer for various public companies, including Armata Pharmaceuticals and Apricus Biosciences, and held leadership roles such as Interim CEO at BakBone Software, Steve Martin has a proven track record in financial leadership within the biotech and technology sectors. Currently, Steve Martin engages as a Board Member for Ensysce Biosciences and other organizations, providing insights and advisory expertise, especially in industries focusing on innovative health solutions. Steve Martin earned a Bachelor of Science in Accounting from San Diego State University between 1979 and 1983.